Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.

COPD affects up to 32 million Americans — half of them undiagnosed. On World COPD Day (Nov. 18), the COPD Foundation is pushing for earlier detection, broader awareness beyond smokers, and better access to new therapies. Leaders say it's one of the most hopeful moments yet for the disease, with new biologics and airway devices on the horizon.
COPD is the fifth leading cause of death in the U.S., yet roughly half of the estimated 32 million Americans living with the disease remain undiagnosed. On World COPD Day (Nov. 18), the COPD Foundation and the Global Initiative for Chronic Obstructive Lung Disease (GOLD) are spotlighting the theme "Early diagnosis and management for a better life" — urging clinicians and patients alike to act before the disease progresses to a debilitating stage.
A key message this year: COPD isn't just a smoker's disease. Veterans, firefighters, nail technicians, people who cook indoors with gas stoves, and those with occupational or environmental exposures are all at risk. Women face unique vulnerabilities due to smaller lung size and different exposure patterns, and often present with shortness of breath rather than classic cough symptoms — making diagnosis trickier.
By the Numbers:
Why it matters: New biologics, inhaled therapies, and airway-stenting devices are expanding treatment options — but they only help patients who know they have the disease. Clinicians are encouraged to screen broadly, assess for comorbidities (cardiovascular disease, anxiety, depression, diabetes), and stay alert to atypical presentations, especially in women and high-risk occupational groups.